1 / 6

Pharma Industry Outlook Pharma Industry Outlook 2025: Trends & Strategies

Healthark Insights shares key trends shaping the pharma industry in 2025u2014from digital transformation to innovation-driven growth strategies.

Healthark
Télécharger la présentation

Pharma Industry Outlook Pharma Industry Outlook 2025: Trends & Strategies

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Pharma Industry Outlook 2025: Trends & Strategies As we move through 2025, the pharmaceutical industry is undergoing a transformation fueled by innovation, data, and a redefined approach to patient care. Here are five strategic shifts reshaping the landscape

  2. Evolving Portfolios Through Scientific Breakthroughs Embracing novel modalities and new MOAs (e.g., Precigen’s non-surgical treatment for RRP) Expanding focus beyond oncology/immunology into Alzheimer’s, weight management, Lp(a)-targeting assets Streamlining pipelines—like Roche narrowing disease areas to drive focus Driving launch excellence with continuous innovation (GSK: 12 launches expected in 2025)

  3. Accelerating R&D with Data, AI & Patient-Centric Trials 85% of execs are investing in AI by 2025 Amgen cut enrollment time in half using ML Sanofi + OpenAI are slashing recruitment time from months to minutes Moderna and Sanofi achieved 80% diversity in trials with online platforms

  4. Building Sustainable, Resilient Supply Chains Geopolitical and margin pressures are prompting investment in smart manufacturing Companies like Amgen and Roche are leading efficiency upgrades

  5. Transforming Customer Engagement Omnichannel personalization via AI (Takeda, Pfizer) Ecosystem collaboration—Novo Nordisk + MIT + Harvard + Broad Institute targeting T2D

  6. Enhancing Patient Engagement Across the Care Journey Digital platforms like PfizerForAll and LillyDirect are revolutionizing access to care and treatment

More Related